Id: acc4923
Group: 1sens
Protein: ERK2
Gene Symbol: Mapk1
Protein Id: P63086
Protein Name: MK01_RAT
PTM: phosphorylation
Site: Tyr187
Site Sequence: HTGFLTEYVATRWYRAPEIML
Disease Category: Cardiovascular and circulatory system diseases
Disease: Pulmonary Artery Proliferation
Disease Subtype: 5-HT induced
Disease Cellline:
Disease Info:
Drug: KMUP-1
Drug Info: KMUP-1 is a novel drug with potential effects in cardiovascular protection and anti - inflammatory activities. It has been investigated for its possible therapeutic applications in relevant pathological conditions.
Effect: modulate
Effect Info: "KMUP-1 inhibits MCT-induced pulmonary artery hyperplasia by binding to 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptors, increasing the expression of endothelial cell eNOS/5-HT(2B) receptors and NO release, and inhibiting the expression of 5-HTT/RhoA/ROCK and the phosphorylation of AKT/ERK. KMUP-1 is promising for the treatment of 5-HT-induced pulmonary artery hyperplasia."
Note:
Score: 4.0
Pubmed(PMID): 20870034
Sentence Index:
Sentence:

Sequence & Structure:

MAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS

Select PDB:

Known Drugs:

source: Multi-Sources

(see table)

No data.

Protein Tractability:

source: Open Targets

No data.

PTM Intensity:

source: CPTAC

No data.

PTM-Disease Association:

source: PTMD
Residue Position State Disease Class PMID
- - A Basophilic leukemia Phosphorylation 11971018
T 183 D Major depressive disorder Phosphorylation 16959794
Y 185 D Major depressive disorder Phosphorylation 16959794
T 183 U Uteroplacental insufficiency Phosphorylation 16940436
Y 185 U Uteroplacental insufficiency Phosphorylation 16940436

State Note: Based on the distinct PTM states in diseases, PTMD classified all disease-associated PTMs into six classes, including whether the up-regulation (U) or down-regulation (D) of PTM levels, the absence (A) or presence (P) of PTMs, and the creation (C) or disruption (N) of PTM sites are associated with diseases.

PTM-Drug Perturbation Response:

source: DecryptM

No data.

Function score:

source: funscoR

No data.

Cross Links: